{"id":"NCT01835470","sponsor":"Bristol-Myers Squibb","briefTitle":"Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan","officialTitle":"A Phase III, Multicenter, Open-Label Study to Assess Efficacy, Safety, Pharmacokinetics and Immunogenicity of Abatacept Administered Intravenously in Japanese Children and Adolescents With Active Juvenile Idiopathic Arthritis Who Have a History of an Inadequate Response or Intolerance to Methotrexate or Biologics","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08-09","primaryCompletion":"2015-11-24","completion":"2018-07-30","firstPosted":"2013-04-19","resultsPosted":"2017-01-11","lastUpdate":"2021-02-26"},"enrollment":23,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Juvenile Idiopathic Arthritis"],"interventions":[{"type":"DRUG","name":"Abatacept","otherNames":["BMS-188667","ONO-4164"]}],"arms":[{"label":"Abatacept","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the efficacy of Abatacept after intravenous administration in Japanese children and adolescents with active juvenile idiopathic arthritis who have a history of an inadequate response or intolerance to Methotrexate or biologics","primaryOutcome":{"measure":"Percentage of Participants Experiencing a American College of Rheumatology (ACR) Pediatric 30 Response at Week 16","timeFrame":"Week 16 (Day 113)","effectByArm":[{"arm":"Abatacept","deltaMin":90,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":13,"countries":["Japan"]},"refs":{"pmids":["31039807"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/s/US/English/USenHome","https://www.bms.com/researchers-and-partners/investigator-inquiry-form.html","https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":20},"commonTop":["NASOPHARYNGITIS","PHARYNGITIS","INFLUENZA","STOMATITIS","LIGAMENT SPRAIN"]}}